Researchers’ perceptions of US Defense Health Agency Institutional Review Board performance

Introduction The US Defense Health Agency (DHA) maintains five Institutional Review Boards (IRBs) within the Office of Human Research Protection Human Research Protection Program (HRPP) to oversee the research portfolio. DHA researchers completed the IRB Researcher Assessment Tool (IRB-RAT) to share their perceptions of IRB performance and identify areas where future process improvement efforts can be focused. Methods This study was a cross-sectional programme evaluation and IRB determination was received. Participants were asked to complete the IRB-RAT. The primary outcome was the performance gap score, calculated for each item as Actual minus Ideal. Linear mixed-effects models were used to analyse responses and to evaluate institutional variability. Results An electronic invitation to complete the IRB-RAT was sent to 5960 registered DHA Electronic IRB system (EIRB) users between May and October 2025. Of those, 473 responded. Analysis identified the most important Ideal characteristics as (Q1) timeliness , (Q4) providing complete explanations for changes and (Q25) not using its power to suppress research . The largest performance gap scores were (Q1) timeliness, (Q24) being an ally rather than a hurdle and (Q15) accountability for errors or delays . Items identified for process improvement were (Q1) timeliness , (Q4) providing complete explanations for changes, (Q24) being an ally rather than a hurdle and (Q22) understanding and acting within their scope of function . There were significant differences across the five IRBs. Performance was not uniform across the DHA. Conclusions The IRB-RAT effectively captured respondents’ perceptions of DHA IRB performance. Timeliness was a universal concern and improvements within IRB scope of function and providing explanations for changes should help minimise delays. Additional work is needed to understand why DHA researchers view the IRB as a hurdle, not an ally. The DHA IRBs must harmonise best practices across the five IRBs and develop future process improvement projects to address researchers’ concerns.

Authors

Institutions

Publication Details

Journal
BMJ Military Health
Published
2026-07-24
DOI
https://doi.org/10.1136/military-2026-003347
Primary Topic
Ethics in Clinical Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Researchers’ perceptions of US Defense Health Agency Institutional Review Board performance

George C. Balazs, Kathryn Bell, Elizabeth A D Dayag
BMJ Military Health
Ethics in Clinical Research
article

Researchers’ perceptions of US Defense Health Agency Institutional Review Board performance

George C. Balazs, Kathryn Bell, Elizabeth A D Dayag
article en

Abstract

Introduction The US Defense Health Agency (DHA) maintains five Institutional Review Boards (IRBs) within the Office of Human Research Protection Human Research Protection Program (HRPP) to oversee the research portfolio. DHA researchers completed the IRB Researcher Assessment Tool (IRB-RAT) to share their perceptions of IRB performance and identify areas where future process improvement efforts can be focused. Methods This study was a cross-sectional programme evaluation and IRB determination was received. Participants were asked to complete the IRB-RAT. The primary outcome was the performance gap score, calculated for each item as Actual minus Ideal. Linear mixed-effects models were used to analyse responses and to evaluate institutional variability. Results An electronic invitation to complete the IRB-RAT was sent to 5960 registered DHA Electronic IRB system (EIRB) users between May and October 2025. Of those, 473 responded. Analysis identified the most important Ideal characteristics as (Q1) timeliness , (Q4) providing complete explanations for changes and (Q25) not using its power to suppress research . The largest performance gap scores were (Q1) timeliness, (Q24) being an ally rather than a hurdle and (Q15) accountability for errors or delays . Items identified for process improvement were (Q1) timeliness , (Q4) providing complete explanations for changes, (Q24) being an ally rather than a hurdle and (Q22) understanding and acting within their scope of function . There were significant differences across the five IRBs. Performance was not uniform across the DHA. Conclusions The IRB-RAT effectively captured respondents’ perceptions of DHA IRB performance. Timeliness was a universal concern and improvements within IRB scope of function and providing explanations for changes should help minimise delays. Additional work is needed to understand why DHA researchers view the IRB as a hurdle, not an ally. The DHA IRBs must harmonise best practices across the five IRBs and develop future process improvement projects to address researchers’ concerns.

BMJ Military Health
Pacific University Oregon (US), Naval Medical Center Portsmouth (US)
Partnerships for the goals
Openalex Percentile: Top 7%
Ethics in Clinical Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.